Meckler Jeffrey A
CIK 0001506916
Co-Chief Executive OfficerDirector10% Owner
Filings
18
Latest May 21, 2026
Issuers covered
2
Showing
18 of 18
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 33% | -1.4% | -0.6% | +23.4% | -26.9% |
| 90 days | 2 | 0% | -15.5% | -15.5% | -7.2% | -23.8% |
| 180 days | 2 | 0% | -29.3% | -29.3% | -28.1% | -30.6% |
| 365 days | 2 | 0% | -50.5% | -50.5% | -30.2% | -70.8% |
Issuers
Companies where Meckler Jeffrey A has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| INDP | Indaptus Therapeutics, Inc. | 11 | Feb 13, 2026 |
| TVTX | Travere Therapeutics, Inc. | 7 | May 21, 2026 |
All filings
18 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|